Triple spike in the works and looks primed to start running right up to the highly anticipated Truforma launch.
Looking to confirm upwards move with a break of the previous high $2.70
Target: $10.80-ish give or take.
Time: 1-2 weeks.
Protected by approximately 70 issued and pending patents, the TRUFORMA diagnostic platform uses Bulk Acoustic Wave (“BAW”) technology, developed by Qorvo (NASDAQ: QRVO), to provide a non-optical and fluorescence-free detection system for use at the point-of-care.
BAW technology, also used in cell phones and in the world’s most advanced radar and communications...
With a clear breakout, and with its new TRUFORMA product, almost ready for commercialization, ZOM is finally showing some strength that I think will persist for Q3 and Q4 of 2021, taking the stock to way higher prices.
The immediate target is the 15 cents level, and then the 20 cents level, watch these. If these higher levels are taken, the stock could see a fast...
